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ABSTRACT
In eukaryotic cells, the Rad6/Rad18-dependent
monoubiquitination of the proliferating cell nuclear
antigen (PCNA) plays an essential role in the
switching between replication and translesion DNA
synthesis (TLS). The DNA polymerase Polg binds
to PCNA via a consensus C-terminal PCNA-
interacting protein (PIP) motif. It also specifically
interacts with monoubiquitinated PCNA thanks to
a recently identified ubiquitin-binding domain
(UBZ). To investigate whether the TLS activity of
Polg is always coupled to PCNA monoubiquitination,
we monitor the ability of cell-free extracts
to perform DNA synthesis across different types
of lesions. We observe that a cis-syn
cyclobutane thymine dimer (TT-CPD), but not a
N-2-acetylaminofluorene-guanine (G-AAF) adduct,
is efficiently bypassed in extracts from Rad18-
deficient cells, thus demonstrating the existence of
a Polg-dependent and Rad18-independent TLS
pathway. In addition, by complementing Polg-
deficient cells with PIP and UBZ mutants, we show
that each of these domains contributes to Polg
activity. The finding that the bypass of a CPD
lesion in vitro does not require Ub-PCNA but never-
theless depends on the UBZ domain of Polg, re-
veals that this domain may play a novel role in
the TLS process that is not related to the
monoubiquitination status of PCNA.
INTRODUCTION
The translesion DNA synthesis (TLS) pathway is respon-
sible for the vast majority of point mutations and is thus
considered as a major process leading to genetic instability
and carcinogenesis. Understanding the molecular mechan-
isms underlying this damage tolerance pathway and its
regulation is therefore of major importance for our under-
standing of human pathogenesis.
In eukaryotes, TLS is carried out by specialized, low
stringency, DNA polymerases belonging to the Y family
(PolZ, Poli, Polk and Rev1) and the B family (Polz).
In vivo or in vitro studies have shown that these DNA
polymerases have various substrate speciﬁcities and that,
in many cases, TLS requires the concerted action of
several TLS polymerases (1,2). Remarkably, human
PolZ has the unique property to replicate past cis-syn
cyclobutane thymine dimers, one of the major photoprod-
ucts induced by UV irradiation, with the same eﬃciency
and accuracy than it does on undamaged DNA (3). The
loss of PolZ activity underlies the high susceptibility to
skin cancers of Xeroderma pigmentosum variant (XP-V)
patients (4,5).
The mechanism by which TLS DNA polymerases gain
access to the lesion site and take over the replicative poly-
merase to incorporate nucleotides opposite the damaged
base is the subject of intense research. Numerous studies
have highlighted the central role of replication processivity
clamps (b-clamp in prokaryotes and PCNA in eucaryotes)
in the ﬁne tuning between replication and TLS. Yeast
PolZ and human TLS polymerases such as PolZ, i and
k functionally interact with the interconnecting loop
of PCNA via their PCNA-interacting protein (PIP)
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PolZ sensitizes yeast cells to UV irradiation (9), while
homologous mutations confer only moderate UV sensitiv-
ity in human cells (10,11). This suggests alternative target-
ing process(es) for the human polymerase. Recently,
Acharya et al. (12) have identiﬁed a functional secondary
PIP domain within the human PolZ that may explain the
above-mentioned modest sensitivity. Furthermore, treat-
ment of yeast or human cells with agents that aﬀect DNA
replication promotes the monoubiquitination of PCNA at
its K164 residue by the Rad6–Rad18 enzyme complex
(13). Genetic studies in Saccharomyces cerevisiae showed
an epistatic relationship between PCNA-K164R mutation
(a non ubiquitinable form of PCNA) and deletion of the
PolZ and Polz TLS polymerases, demonstrating that TLS
in this organism is largely dependent on the
monoubiquitination of the replication processivity clamp
(14). Vertebrate Y-family DNA polymerases preferentially
interact with the monoubiquitinated form of PCNA
(15,16) via Ubiquitin (Ub) binding domains designated
UBZ (PolZ and Polk) or UBM (Poli and Rev1) that are
required for their relocalization in nuclear foci after UV
irradiation (10,17–19). In addition, it has been observed
that some mutations in the UBZ domain of human PolZ
have a much more drastic eﬀect on UV cell survival than
mutations in the C-terminal PIP domain (10).
Consequently, it has been proposed that the binding of
Y-family polymerases to the Ub moiety of PCNA is
required for their access to the site of a stalled replication
fork. Such a model highlighting a crucial role of PCNA
ubiquitination in the regulation of TLS should however be
tempered by the results on the extensive mutational
analysis of the UBZ domain of PolZ conducted by
Acharya et al. (12,20), which suggest that the binding of
the Ub moiety by PolZ is not a necessary requirement for
the ability of this polymerase to function in TLS of
UV-induced DNA lesions.
Besides its role in facilitating the access of TLS poly-
merases to the lesion site, monoubiquitination of PCNA
may also increase the kinetic of TLS by specialized
DNA polymerases. Indeed, it has been shown that
monoubiquitinated PCNA (Ub-PCNA) is more eﬀective
than the unmodiﬁed clamp in promoting yeast PolZ or
Rev1 TLS activity across an abasic site in vitro (21).
However, such a kinetic activation by Ub-PCNA was
not conﬁrmed in another study (22). Finally, TLS in ver-
tebrate cells appears to be only partially dependent on
Rad18 activity since UV-mutagenesis is reduced only
2-fold, in Rad18
KO (knock out) mouse cells (23).
Furthermore, defective ubiquitination of PCNA in the
chicken cell line DT40 is not epistatic to Polk and Rev1
mutants for UV sensitivity (24,25) indicating that at least
these Y-family polymerases may be recruited in a
Rad18-independent manner.
Taken together these data illustrate many aspects on the
regulation of TLS by the post-translational status of
PCNA that remain unclear and much debated. In an
eﬀort to elucidate these mechanisms and to investigate
whether a Rad18-independent TLS pathway might
operate in mammalian cells, we used Rad18-deﬁcient
cells and stable XPV ﬁbroblast cell lines (XP30RO)
complemented with PolZ polymerases mutated in either
their PIP or UBZ motifs. Protein extracts from these cell
lines were prepared in order to analyze their ability to
perform TLS across diﬀerent DNA lesions. We could
thus monitor the activity of PolZ in the presence or in
the absence of Rad18 and PCNA ubiquitination, and
the activity of PolZ variants that are diﬀerentially
aﬀected in their binding capacity to PCNA and/or to ubi-
quitin. We show that while Rad18 is required for the
bypass of a N-2-acetylaminoﬂuorene-guanine (G-AAF)
lesion in cell-free extracts, it is dispensable for the
bypass of a TT-CPD lesion. This implies that, under the
experimental conditions tested here, the PolZ-dependent
bypass of CPD is independent of Ub-PCNA. However, we
also demonstrate that both the PIP and UBZ domains of
PolZ facilitate the TLS reaction across both lesions. This
result indicates that, in addition to its documented role in
Ub-PCNA binding, the UBZ domain of PolZ may play a
novel role in the TLS process that is not related to the
ubiquitination status of PCNA.
MATERIAL AND METHODS
Plasmids and cell lines
Cells were grown at 37 C in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal calf
serum and gentamicin (0.5mg/ml).
The human colon carcinoma cell line HCT116-
Rad18
KO cell line (26) was cultured in the presence of
G418 (300mg/ml) and puromycin (0.3mg/ml). MRC5-V1
cells are SV40-transformed normal human lung ﬁbroblasts
(27). The XP30RO cell line (SV40-transformed
X. pigmentosum variant human ﬁbroblasts) has a homo-
zygous deletion in the PolZ gene resulting in a truncated
protein of only 42 amino acids (4). XP30RO cell lines ex-
pressing wild type (wt) or mutated forms of PolZ were
generated by transfection with a pcDNA3.1/zeo( )
plasmid harboring the corresponding PolZ sequence
(kindly provided by P. Kannouche); transfected cells
were thereafter selected with zeocin. Mutations in the
coding sequence of PolZ were generated by site-directed
mutagenesis. The sequences of the primers used for the
generation of the D652A mutation are: 50-CCAGAACA
CATGGCATATCATTTTGCA-30 and: 50-CATATCCC
ATACCGGTACCAGGGA-30. The PIP deletion,
generated by introducing a stop codon at position 705,
consists in a deletion of the last nine amino acids of the
PolZ amino acid sequence (QTLESFFKPLTH ! QTL).
The sequences of the primers used for mutagenesis are:
50-GAATCATTTTTTAAGCCATTAACA-30 and 50-AC
AATGTTTGCATGCCCTCAGGCCT-30.
Rad18 gene silencing in MRC5 cells
siRNA design, cloning in pEBV vectors carrying a
hygromycin B resistance cassette and establishment of
stable knockdown or control cells were carried out as pre-
viously described (28). The RNAi sequence for Rad18
(NM_020165) stretches nucleotides 1459–1477. Control
cells were obtained by stable transfection with the
pBD650 vector that carries an ineﬃcient shRNA (28).
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designated as MRC5-Rad18
KD and MRC5-CT, respect-
ively. The transformed MRC5 cell lines were cultured in
presence of hygromycin B (150mg/ml, Roche).
Cell survival analysis
Cells were plated at 4000 (XP30RO) or 2500 (MRC5) cells
per 10cm diameter dish 24h before UV irradiation
(254nm). After 7 days of culture in the presence of
caﬀeine (1mM), growing clones were ﬁxed with 4%
paraformaldehyde and stained with crystal violet in 10%
ethanol. Clones containing more than 50 cells were
counted. Experiments were performed at least four
times. Colony formation was normalized as a percentage
of the non-irradiated control.
Immunostaining
Cells grown on coverslips were UV-irradiated (15J/m
2)
and cultured for 4h. The cells were ﬁxed with methanol/
acetone (1/1, v/v) for 30min at 4 C and washed three
times with phosphate-buﬀered saline (PBS) supplemented
with Tween-20 (0.1%; v/v). Cells were stained by over-
night incubation (4 C) with a monoclonal anti-Rad18
antibody (Rad18 Ab57447, Abcam, 1:500 dilution)
washed three times with PBS supplemented with
Tween-20 (0.1%; v/v), and incubated for at least 2h at
room temperature with Alexa Fluor 488 goat anti-mouse
IgG (1:2000, Molecular Probes). Observations were made
with a Leica TCS4D confocal microscope equipped with
an argon/krypton laser and suitable barrier ﬁlters.
Immunoblotting
Cell-free extracts (100mg) were loaded onto SDS/poly-
acrylamide gels. After electrophoresis, separated proteins
were transferred onto a PVDF membrane (Biorad) and
probed with antibodies against PolZ (C17, sc-5938), Pold
(A9, sc-17776) and PCNA (PC10, sc-56) from Santa Cruz
Biotechnology. Anti-HA antibody (HA.11) was purchased
from Covance.
Primer extension analysis and in vitro PCNA
monoubiquitination assay
Construction of single-stranded plasmids containing
either a CPD lesion (pUC-CPD.ss) or a single unique
G-AAF adduct (pUC3G1-AAF.ss) has been extensively
described (29). Primer extension analysis and standard
ubiquitination assays were performed as previously
described (30,31). Brieﬂy, the reaction mixture (6.25ml)
containing 10 fmol of primed DNA and the whole-cell
extract was incubated at 37 C in 50mM HEPES–KOH
(pH 7.8), 7mM MgCl2, 1mM DTT, 4mM ATP, 500mM
of dNTPs, 40mM creatine phosphate and 100mg/ml
creatine kinase. The reaction was stopped by adding an
equal volume of proteinase K-SDS (4mg/ml, 2%) and
incubated for 30min at 37 C. Puriﬁed replication
products were further digested with EcoRI and PvuII re-
striction enzymes and analyzed by electrophoresis on a
polyacrylamide–7M urea denaturing gel. Quantiﬁcation
of the levels of TLS was determined by phospho-imager
analysis.
RESULTS
Rad18 is dispensable for the in vitro bypass of a CPD
lesion while it is required for the bypass of an AAF adduct
In order to investigate whether PolZ functions were
strictly dependent on Ub-PCNA and whether this may
depend upon the nature of the DNA lesion, we
compared the ability of extracts from Rad18-proﬁcient
(wild type) or Rad18-deﬁcient (Rad18
KO) HCT116 cells
to synthesize DNA opposite either a CPD or an AAF
lesion. HCT116-Rad18
KO cells were signiﬁcantly more
sensitive than wild-type HCT116 to DNA-damaging
agents such as cisplatin and methyl methanesulfonate
but only moderately sensitive to UV (26). Strikingly, the
diﬀerence between wild-type and Rad18-deﬁcient cells was
only detectable at high UV doses (Figure 1A). By using
single-stranded mono-modiﬁed plasmids, we have already
shown that normal cell extracts are able to bypass a
blocking lesion such as a G-AAF adduct (30). In this
assay, the replicative machinery that extends the
radiolabeled primer (located 91 nucleotides away from
the adduct site), is blocked one nucleotide before the
lesion (L-1; Figure 1C). PolZ carries out the incorporation
of a few nucleotides opposite and beyond the lesion site,
and is then probably replaced by the replicative polymer-
ase, as judged by the comparison of the extension proﬁles
obtained with normal and XPV cell extracts (Figure 1C),
or with XPV extracts complemented with PolZ
(Supplementary Figure S1A). Therefore, our in vitro
assay may mimic the successive steps promoting the
access of TLS polymerases to damaged DNA. Indeed,
we have clearly established that PCNA is required
for the TLS reaction (Supplementary Figure S1B).
Furthermore PCNA is monoubiquitinated during such
primer extension reactions (31). This post-translational
modiﬁcation of PCNA depends on both relatively long
tracts of DNA synthesis and upon the presence of
replication hurdles such as hairpin structures or a single
G-AAF adduct or a TT-CPD lesion (31 and
Supplementary Figure S2). The ability of cell-free
extracts to perform both PCNA monoubiquitination and
DNA synthesis across a lesion gives us the unique oppor-
tunity to investigate whether the TLS activity of PolZ is
coupled to this modiﬁcation.
During primer extension, Ub-PCNA formation is easily
detectable in HCT116 cell-free extracts, while it is abol-
ished in HCT116-Rad18
KO cell-free extracts (Figure 1B).
This demonstrates that under our conditions, the
monoubiquitination reaction observed in cell-free extract
is totally Rad18-dependent. As shown in Figure 1C, we
observed that HCT116 cell-free extracts are able to bypass
both CPD and AAF lesions, although higher eﬃciencies
were observed for CPD. Extracts prepared from XP30RO
cells which lack PolZ are largely defective in TLS past
either AAF or CPD lesions, indicating that PolZ is
involved in the bypass of both lesions. In Rad18-deﬁcient
cells, the bypass of the CPD lesion is as eﬃcient as in
6458 Nucleic Acids Research, 2010,Vol.38, No. 19wild-type cell extracts, while the bypass of the AAF
adduct is totally abolished (Figure 1C). These results
were further conﬁrmed in a time course experiment
showing that prolonged incubation of up to 60min did
not allow the bypass of an AAF adduct to occur in the
absence of Rad18 (data not shown). Conversely, the
kinetics of TLS through the CPD lesion in both
HCT116 and HCT116-Rad18
KO extracts are equivalent
(Figure 1D). Together, these results indicate that Rad18
per se or the ubiquitination of PCNA is dispensable for
the bypass of this lesion during primer extension in
cell-free extracts.
We were concerned that the moderate UV sensitivity of
HCT116-Rad18
KO cells as compared to HCT116 cells
might reﬂect a particular UV damage tolerance of this
cell line that may interfere with the PolZ pathway. In
order to conﬁrm the results obtained with HCT116-
Rad18
KO cells, we thus have extended our analysis on
TLS eﬃciency through CPD and AAF lesions by using
a SV40-transformed MRC5 human ﬁbroblast cell line in
which Rad18 was stably silenced by means of long-term
RNA interference. To assess the eﬃciency of Rad18
silencing, an MRC5 cell line ectopically expressing
HA-tagged Rad18 protein was transfected with pEBV
coding for shRNA against Rad18. After isolation of
stable transformants upon hygromycin B selection,
protein extracts were analyzed by immunoblotting with
an anti-HA antibody. As shown in Figure 2A, expression
of HA-Rad18 was drastically reduced in three independ-
ent cell clones expressing the shRNA against Rad18, while
HA-Rad18 was readily detected as two bands, in extracts
from either non-transfected cells (MRC5-HARad18-NT)
or cells that express a non-related shRNA sequence
(MRC5-HARad18-CT). This result demonstrates the ef-
fectiveness of the Rad18 shRNA sequence for silencing
Rad18 expression. Therefore, this sequence was subse-
quently used to generate a MRC5-Rad18KD cell line in
which endogenous Rad18 depletion was monitored by
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(Figure 2B). The disappearance of the Rad18 signals in
both non-irradiated and UV-irradiated MRC5-Rad18
KD
cells demonstrate the eﬃciency of Rad18 depletion in the
selected clone (Figure 2B). Eﬃcient silencing of Rad18 in
this cell line was further conﬁrmed by the absence of
PCNA monoubiquitination after UV irradiation (data
not shown). MRC5-Rad18
KD cells also show increased
sensitivity to UV as compared to MRC5 or MRC5-CT
cells that express a non-related shRNA sequence
(Figure 2C).
We previously noticed that induction of Ub-PCNA
during primer extension is much more eﬃcient than that
after UV irradiation of cultured cells (31). While
Ub-PCNA is easily observable in control cell extracts, it
is barely detected in MRC5-Rad18
KD cell extracts (Figure
2D). As shown previously with HCT116 cells, extracts
prepared from both Rad18-proﬁcient and -deﬁcient
MRC5 cells were able to carry out TLS through a CPD
lesion with equal eﬃciency (Figure 2E). In contrast,
MRC5-Rad18
KD extracts show reduced TLS capacities
opposite an AAF adduct (Figure 2E). Quantitative
analysis of the data shows that TLS activity through an
AAF-modiﬁed substrate in the MRC5-Rad18
KD cell
extracts drops to about 50% of that measured in control
cell extracts. We consider that the remaining PCNA
monoubiquitination observed in MRC5-Rad18
KD cell
extracts (Figure 2D) may be responsible for the residual
PolZ-dependent TLS activity through an AAF adduct in
these assays.
Data from both HCT116-Rad18
KO and MRC5-
Rad18
KD cell extracts demonstrate that Rad18 activity is
dispensable for the bypass of a CPD lesion in vitro while it
is required for the bypass of an AAF adduct. Altogether,
our observations strongly suggest the existence of both
Rad18-dependent and -independent PolZ-mediated TLS
pathways.
UV survival of XP30RO cells expressing PIP and UBZ
mutants of Polg
The PolZ-deﬁcient XP30RO cell line was used to generate
several clones stably expressing diﬀerent mutants of PolZ.
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amino acids of the PolZ sequence containing the PCNA
binding site consensus sequence (6,32). The UBZ mutation
consists of a D to A mutation at position 652. The
solution structure of this domain shows a classical
zinc-ﬁnger structure coupled with a carboxy-terminal, a
helix that mediates the interaction with ubiquitin (33).
The D652 residue, lying in the a-helix, is conserved in
both yeast and vertebrate PolZ and was shown, by
co-immunoprecipitation assays and by yeast two-hybrid
analysis (10; A.C., unpublished results) to be essential
for Ub binding. The single D652A as well as the double
mutant D652A-PIP were constructed.
The UV sensitivity of stable transformants expressing
mutated PolZ was determined using a colony-forming
assay (Figure 3). XP30RO cells expressing either
wild-type PolZ (WT) or the empty vector (V) were
included as positive and negative controls, respectively.
We found a strong positive correlation between the
ability of PIP PolZ mutants to complement the UV sen-
sitivity of XPV cells and the level of ectopic expression of
the PolZ protein in the diﬀerent clones analyzed
(Figure 3A and C). This result emphasizes the crucial im-
portance of controlling the expression level of a protein in
complementation assays. Indeed, while high levels of ex-
pression of the PIP PolZ allows an almost complete res-
toration of UV survival, the PIP mutant clone
expressing the lowest levels of PolZ fails to eﬃciently com-
plement the UV sensitivity of XPV cells.
On the other hand, the UBZ domain mutant, is only
partially able to complement the UV sensitivity of XPV
cells, whatever its expression level (Figure 3B and C).
Finally, the UV survival of the transfectant expressing a
high level of the double mutant D652A-PIP PolZ was
signiﬁcantly lower than either of the single mutants
(Figure 3B). Altogether, these observations are consistent
with a model in which both the PIP motif and the D652
residue within UBZ domain contribute to the in vivo func-
tions of PolZ.
Both PIP and UBZ domains of Polg contribute to CPD
and AAF bypass in vitro
In order to analyze the contribution of the PIP and/or
UBZ domains to PolZ’s TLS function, extracts from
cells expressing the diﬀerent mutants were prepared and
assayed for in vitro bypass through either CPD or AAF
lesions. With extracts from cell lines expressing the
mutated PolZ at moderate levels (lower than 10-fold
above the MRC5 basal level; Figure 4B), we observed a
decrease in the amount of TLS products in comparison
with the wild-type control (Figure 4A). These results
suggest that mutations in either of these two domains sig-
niﬁcantly reduce the bypass eﬃciency through both
lesions, even if the PIP truncation appears to have a
more pronounced eﬀect than the D652A mutation on
the bypass eﬃciency (compared at identical levels of
PolZ expression: lanes 2 with lanes 6 and lanes 3 with
lanes 7).
Finally, cell extract from the D652A-PIP PolZ double
mutant, although containing a high level of PolZ cannot
restore eﬃcient TLS through G-AAF or TT-CPD lesions.
Altogether, these data show that, in accordance with the
in vivo studies, both regions of PolZ participate to its
function. Interestingly, despite the independence of the
CPD bypass with regard to Rad18, the D652 residue
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D652A mutants (DA) and D652A-PIP mutant (DA-PIP); V, empty
vector. The numbers in front of the diﬀerent cell lines indicate the
expression levels of ectopic PolZ as compared to MRC5 cells (Figure
4B). (C) Survival of XP30RO and XP30RO transformed cell lines ex-
pressing diﬀerent levels of mutant PolZ following UV irradiation at
12J/m
2.
Nucleic Acids Research, 2010,Vol.38, No. 19 6461within the UBZ domain contributes to the bypass of a
CPD lesion in vitro. In turn, this points to a speciﬁc role
of the D652 residue that does not involve interaction of
PolZ with the ubiquitin moiety of the modiﬁed PCNA.
DISCUSSION
Bypass of TT-CPD, in contrast to G-AAF, is
independent of Rad18 in cell-free extracts
Our results demonstrate that, in cell-free extracts, Rad18
is dispensable for the bypass of a CPD lesion while it is
required for the bypass of an AAF adduct (Figures 1 and
2). While we cannot rule out a minor undetectable
Rad18-independent monoubiquitination of PCNA
(34–36), we infer from these data that CPD bypass in
cell-free extracts is independent of Ub-PCNA. Our obser-
vation is consistent with a recent report showing that PolZ
is able to gain access to replication complexes and to
catalyze TLS through CPD dimers in the presence of the
non-ubiquitinable K164R PCNA mutant during replica-
tion of double-stranded DNA in HeLa cell-free extracts
(37). What could be the rationale for such a diﬀerence
between the CPD lesion and the AAF adduct? One
obvious diﬀerence is the facility by which each of these
lesions is bypassed by PolZ. Steady-state kinetic analysis
have shown that puriﬁed yeast and human PolZ can rep-
licate through a T–T CPD dimer with the same kinetics
and ﬁdelity as through an undamaged T–T sequence
(38,39), while the bypass kinetics of a G-AAF adduct by
puriﬁed human PolZ is signiﬁcantly lower (40). By altering
the PolZ–PCNA interaction, monoubiquitination of the
clamp may directly stimulate PolZ TLS activity through
the AAF adduct, as previously shown in vitro for an abasic
site (21). Ub-PCNA may also recruit additional co-factors
that could facilitate the PolZ-dependent bypass of the
AAF adduct. Alternatively, Rad18 per se may be
required for this speciﬁc reaction since it has been shown
that interaction of Rad18 with PolZ participates in the
polymerase function in vivo (16).
Contributions of the PCNA- and ubiquitin-binding
domains to the activity of Polg in vivo
We examined the ability of PIP truncation and D652A
PolZ mutants to complement the UV sensitivity of
XP30RO cell line. Consistent with the predicted essential
role of the PIP domain in PCNA binding, we found that
expression of the PIP PolZ mutant (even ﬁvefold above
the MRC5 basal level) results in a substantial sensitization
of the cells as compared to those expressing exogenous
WT PolZ. Surprisingly, this mutation can be compensated
by high overexpression of the mutant polymerase, raising
the possibility that the secondary PIP domain recently
identiﬁed within the PolZ sequence (12) may substitute
for the C-terminal one, although with a lower eﬃciency.
The hypothesis that the binding of the Ub moiety on
PCNA via the UBZ domain may replace the PolZ PIP–
PCNA interaction seems unlikely since recent structural
studies have shown that the PIP motif contributes more
signiﬁcantly to the interaction between PolZ and PCNA
than the UBZ domain (33,41). Alternatively, the defect in
the targeting of PolZ to the DNA template/primer
junction by the C-terminal PIP domain might be
compensated by interaction with other proteins, such as
Rad18 or Rev1, that may recruit PolZ to the replication
stalling sites (16,42).
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Figure 4. Relative contribution of the PIP and UBZ domains of PolZ for the in vitro bypass of CPD and AAF lesions. (A) Cell-free extracts were
prepared from the various complemented XP30RO cell lines (see legend to Figure 3) and tested for their ability to perform TLS through AAF and
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raised against PolZ. As a loading control, the same membrane was blotted with antibodies against p125, the catalytic subunit of Pold.
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that a mutation of the D652 residue resulted in UV sen-
sitivity in yeast and human cells (12,20,43). When
overproduced about 10-fold, both D652A and PIP
PolZ mutants partially complement the UV sensitivity of
XPV cells to the same extent. While complementation by
the PIP PolZ mutant varies notably with the expression
level within a 1- to 10-fold overexpression range, comple-
mentation with the D652A PolZ mutant does not change
signiﬁcantly with the level of overproduction (Figure 3C).
We conclude from these results that the D652 residue of
PolZ participates in a speciﬁc role that is not exchangeable
with that of the PIP domain and that is essential for full
activity of PolZ.
Alternative models for the role of the Polg UBZ domain
in TLS through a CPD lesion
We also examined the eﬀects of PolZ PIP truncation and
D652A mutation on the ability of cell-free extracts to
promote TLS through a CPD lesion and an AAF
adduct. We observed that whatever the lesion, both mu-
tations impair TLS eﬃciency in vitro. This result together
with the UV survival analysis of XP30RO cells comple-
mented with PIP and UBZ mutants, are in agreement with
a model in which both regions contribute to PolZ function
in TLS (10,12,20,43). The dependence of TLS on the PIP
motif conﬁrms the involvement of PCNA in the reaction
since it has been shown that this motif mediates a func-
tional interaction between PolZ and PCNA (6).
Interestingly, while Rad18 is not required for the bypass
through a CPD lesion, we observed that the D652 residue,
which is involved in the interaction with ubiquitin, con-
tributes to this reaction. This result suggests that, for the
bypass of this speciﬁc lesion, the UBZ domain of PolZ
may bind the ubiquitin moiety of a modiﬁed protein
that is ubiquitinated in a Rad18-independent manner.
Another possibility might be that the D652A mutation
abrogates a novel, uncharacterized, function of the PolZ
UBZ domain that is distinct from ubiquitin binding. In
agreement with this latter interpretation, recent genetic
data provide evidences that some mutations in the C2H2
motif of the UBZ domain of PolZ impair the binding to
ubiquitin but have no perceptible eﬀect on UV sensitivity
and UV mutagenesis (12,20), suggesting that the binding
of ubiquitin by PolZ via its UBZ domain is not a necessary
prerequisite for PolZ to function in TLS.
CONCLUSION
Despite the recent advances in the knowledge of the TLS
process, the mechanisms by which the TLS Pols gain
access to the template–primer junction when the replica-
tive machinery encounters a blocking lesion remain
unclear. Several data indicate that PolZ contributes not
only to gap ﬁlling after the replication apparatus has
moved away from the damaged site, but also helps to
maintain the continuous progression of the replication
fork after DNA damaging treatment. Indeed, as
compared to WT cells, XPV cells accumulate shorter rep-
lication products after UV irradiation and elongation of
these intermediates was markedly retarded (25,44). We
propose that, depending on the nature of the lesion (and
its sequence context), diﬀerent mechanisms control PolZ
activity. Eﬃcient bypass of lesions that do not require
Rad18-dependent PCNA monoubiquitination, as a T–T
CPD dimer, may occur ‘on the ﬂy’ during processive
DNA synthesis, without actual uncoupling of the replica-
tive polymerases. If this ﬁrst TLS trial is not successful,
the uncoupling of leading and lagging strand synthesis
provides the substrate for Rad6/Rad18-dependent
PCNA monoubiquitination. Rad18 and Ub-PCNA may
then facilitate the bypass reaction as exempliﬁed here by
the analysis of the AAF adduct TLS. We were concerned
that our system may not be fully relevant to test this
model, since the CPD lesion is located on a ssDNA
template and is thus able to stimulate PCNA
monoubiquitination in the absence of fork uncoupling
(Supplementary Figure S2). However, as shown in
Figures 1 and 2, this modiﬁcation is clearly dispensable
for PolZ to bypass a CPD lesion.
We have established that in cell-free extracts, TLS of
both an AAF adduct and a CPD lesion requires the
UBZ domain. We speculate that this domain plays a
dual role in the TLS process. On one hand, it may
mediate the binding to Ub-PCNA during the gap ﬁlling
reaction. On the other hand, the D652 residue may par-
ticipate in a distinct function, such as the interaction with
another protein that is necessary for the coordination of
the PolZ activity at the replication fork. In agreement with
this model, Edmunds et al. (25) have recently shown that,
in DT40 cells, PCNA monoubiquitination is dispensable
for maintaining replication fork progression on damaged
DNA while it is required post-replicatively. Interestingly,
the data presented in this latter paper show that the UBM
domains of Rev1 are required for its activity at the repli-
cation fork in the absence of Ub-PCNA. Thus, it is con-
ceivable that the regulatory mechanism described in this
study may apply to the UBD domain of Y-family poly-
merases in general.
SUPPLEMENTARY DATA
Supplementary data are available at NAR Online.
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